Growth Metrics

Madrigal Pharmaceuticals (MDGL) Net Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 32.79%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 60.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -46.86%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.80%
7 Evaxion A 64.16 Bn 64.14 Bn - 19.97%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 47.10%
10 Madrigal Pharmaceuticals 14.44 Bn 14.20 Bn - -6.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.27%
Dec 31, 2025 12.05%
Sep 30, 2025 -11.02%
Jun 30, 2025 15.79%
Mar 31, 2025 -8.39%
Dec 31, 2024 2.72%
Sep 30, 2024 -19.23%
Jun 30, 2024 -35.08%
Mar 31, 2024 -40.83%
Dec 31, 2023 -23.80%
Sep 30, 2023 -19.43%
Jun 30, 2023 -20.43%
Mar 31, 2023 -28.62%
Dec 31, 2022 -45.76%
Sep 30, 2022 -55.90%
Jun 30, 2022 -53.13%
Mar 31, 2022 -56.24%
Dec 31, 2021 -77.85%
Sep 30, 2021 -94.98%
Jun 30, 2021 -109.97%
Mar 31, 2021 -102.47%
Dec 31, 2020 -89.45%
Sep 30, 2020 -89.91%
Jun 30, 2020 -80.54%
Mar 31, 2020 -81.95%
Dec 31, 2019 -53.27%
Sep 30, 2019 -15.15%
Jun 30, 2019 -90.31%
Mar 31, 2019 -103.48%
Dec 31, 2018 -2.89%
Sep 30, 2018 -67.85%
Jun 30, 2018 30.45%
Mar 31, 2018 32.52%
Dec 31, 2017 24.68%
Sep 30, 2017 24.88%
Jun 30, 2017 27.92%
Mar 31, 2017 36.62%
Dec 31, 2016 31.68%
Sep 30, 2016 14.57%
Jun 30, 2016 49.94%
Mar 31, 2016 55.80%
Dec 31, 2015 16.54%
Sep 30, 2015 50.67%
Jun 30, 2015 -10.64%
Mar 31, 2015 -11.22%
Dec 31, 2014 -23.74%
Sep 30, 2014 -16.17%
Jun 30, 2014 -21.25%
Mar 31, 2014 -27.37%
Dec 31, 2013 -39.91%
Sep 30, 2013 -29.94%
Jun 30, 2013 -35.92%